Health-related quality of life in men with erectile dysfunction

Journal of General Internal Medicine

Volumn 13, Issue 3, 1998, Pages 159-166

  Litwin, Mark S ^a,b   Nied, Robert J ^a   Dhanani, Nasreen ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Erectile dysfunction; Health related quality of life; Impotence; Medical outcomes

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; HUMAN; IMPOTENCE; MAJOR CLINICAL STUDY; MALE; PENIS ERECTION; QUALITY OF LIFE; RATING SCALE; SEXUAL BEHAVIOR; TREATMENT OUTCOME;

COMORBIDITY; EMOTIONS; HEALTH STATUS; HEALTH SURVEYS; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; SEXUAL PARTNERS; SOCIOECONOMIC FACTORS;

EID: 0031909584     PISSN: 08848734     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1497.1998.00050.x     Document Type: Article

References (30)

1. Althof S, Turner L, Levine S, et al. Why do so many people drop out from auto-injection therapy for impotence? J Sex Marital Ther. 1989;15:121-9.
2. 1, papaverine and phentolamine in nonresponders to high papaverine plus phentolamine doses. J Urol. 1996;155:913-4.
3. Gee WF, Holtgrewe HL, Albertson PC, et al. Practice trends of American urologists in the treatment of impotence, incontinence, and infertility. J Urol. 1996;156:1778-80.
4. Hollander JB, Gonzalez J, Norman T. Patient satisfaction with pharmacologic erection program. Urology. 1992;39:439-41.
5. 1 for impotency. Urology. 1994;43:84-7.
6. Turner LA, Althof SE, Levin SB, Bodner DR, Kursh ED, Resnick MI. Twelve-month comparison of two treatments for erectile dysfunction: self-injection versus external vacuum devices. Urology, 1992;39:139-44.
7. 1 as treatment for erectile dysfunction. J Urol. 1996;155:915-7.
8. Hedlund H, Anderson K-E. Contraction and relaxation induced by some prostenoids in isolated human penile erectile tissue and cavernous artery. J Urol. 1985;134:1245-50.
9. 1 in erectile failure: a survey of worldwide experience. J Urol. 1996;155:802-15.
10. Sidi AA, Reddy PK, Chen KK. Patient acceptance of and satisfaction with vasoactive intracavernous pharmacotherapy for impotence. J Urol. 1988;140:293-4.
11. Padma-Nathan H, Hellstrom WJ, Kaiser FE, et al. Treatment of men with erectile dysfunction with transurethral alprostadil. N Engl J Med. 1997;336:1-7.
12. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994; 151: 54-61.
13. Mulligan T, Moss CR. Sexuality and aging in male veterans: a cross-sectional study of interest, ability, and activity. J Arch Sex Behav. 1991;20:17-25.
14. Carrier S, Brock G, Kour NW, Lue TF. Pathophysiology of erectile dysfunction. Urology. 1993;42:468-81.
15. 1 for erectile dysfunction. J Urol. 1996;156:80-1.
16. Helgason A, Fredrikson M, Adolfsson J, Steineck G. Decreased sexual capacity after external radiation therapy for prostate cancer impairs quality of life. Int J Radiat Oncol Biol Phys. 1995; 32:33-9.
17. Litwin MS. Measuring health-related quality of life in men with prostate cancer. J Urol. 1994;152:1882-7.
18. Ware JE, Sherbourne CD. The MOS 36-Item short-form health survey (RAND 36-Item Health Survey), I: conceptual framework and item selection. Med Care. 1992;30:473-83.
19. Stewart AL, Greenfield S, Hays RD, et al. Functional status and well-being of patients with chronic conditions: results from the Medical Outcomes Study. JAMA. 1989;262:907-13.
20. Ware JE, Snow KK, Kosinski M. et al. RAND 36-Item Health Survey: Manual and Interpretation Guide. Boston, Mass: The Health Institute, The New England Medical Center; 1993.
21. Litwin MS, Hays RD, Fink A, et al. Quality of life outcomes in men treated for localized prostate cancer. JAMA. 1995;273:129-35.
22. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med. 1993;118:622-9.
23. Ganz PA, Schag CAC, Lee JJ, et al. The CARES: a generic measure of health-quality of life for patients with cancer. Qual Life Res. 1992;1:19-29.
24. Schag CAC, Ganz PA, Heinrich RL. Cancer Rehabilitation Evaluation System Short Form (CARES-SF): a cancer-specific rehabilitation and quality of life instrument. Cancer. 1991;68:1404-13.
25. Schag CAC, Heinrich RL. Cancer Rehabilitation Evaluation System (CARES) Manual. Los Angeles, Calif: CARES Consultants; 1988.
26. Schag CAC, Heinrich RL. Development of a comprehensive quality of life measurement tool: CARES. Oncology. 1990;4:135-8.
27. Greenfield S, Apolone G, McNeil BJ, Cleary PD. The importance of coexistent disease in the occurrence of post-operative complications and one-year recovery in patients undergoing total hip replacement: comorbidity and outcomes after hip replacement. Med Care. 1993;31:141-54.
28. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16:297-334.
29. Ware JE, Kosinski M, Keller SK. SF-36 Physical and Mental Health Summary Scales: A User's Manual. Boston, Mass: The Health Institute, New England Medical Center; 1994.
30. Testa MA, Simonson DC. Assessment of quality-of-life outcomes. N Engl J Med. 1996;334:835-40.